Clinical Trial NCT05646563
Trial
NovelMed – NM8074
Clinical trial ID
NCT05646563
Drug name
---
Company:
NovelMed
Drug trade name
---
Phase of study
2
Current status
Not yet recruiting
Start
9/2023
Substance
monoclonal antibody
Research question
Mono vs eculizummab addon therapy to assess safety, efficacy and immunogenicity
Delivery method of drug
i.v.
Frequency
every 4 weeks/2 weeks
Clinical trial locations
tbd